Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections

World Journal of Gastroenterology

Volumn 22, Issue 11, 2016, Pages 3078-3104

  McFarland, Lynne Vernice ^a   Ozen, Metehan ^b   Dinleyici, Ener Cagri ^c   Goh, Shan ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ACIBADEM UNIVERSITY   (Turkey)

^c ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Adults; Antibiotic associated diarrhea; Antibiotics; Clostridum difficile infections; Diarrhea; Pediatrics; Prevention; Risk factors; Treatments

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; METRONIDAZOLE; PROBIOTIC AGENT; RNA 16S; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; DISEASES; ENVIRONMENTAL FACTOR; EPIDEMIC; HUMAN; INCIDENCE; INCUBATION TIME; INFECTION CONTROL; PREVALENCE; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SYMPTOM; TREATMENT RESPONSE; ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; CHEMICALLY INDUCED; CHILD; COMPARATIVE STUDY; DIARRHEA; DRUG EFFECTS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; INFANT; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PEPTOCLOSTRIDIUM DIFFICILE; PRESCHOOL CHILD; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INCIDENCE; INFANT; MIDDLE AGED; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84960911177     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i11.3078     Document Type: Review

References (225)

1. McFarland LV, Brandmarker SA, Guandalini S. Pediatric Clostridium difficile: a phantom menace or clinical reality? J Pediatr Gastroenterol Nutr 2000; 31: 220-231. [PMID: 10997362
2. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478-498; quiz 499. [PMID: 23439232
3. Cheng AC, Ferguson JK, Richards MJ, Robson JM, Gilbert GL, McGregor A, Roberts S, Korman TM, Riley TV. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Med J Aust 2011; 194: 353-358. [PMID: 21470086
4. Wendt JM, Cohen JA, Mu Y, Dumyati GK, Dunn JR, Holzbauer SM, Winston LG, Johnston HL, Meek JI, Farley MM, Wilson LE, Phipps EC, Beldavs ZG, Gerding DN, McDonald LC, Gould CV, Lessa FC. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 2014; 133: 651-658. [PMID: 24590748. DOI: 10.1542/peds.2013-3049
5. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16: 604-609. [PMID: 20350373. DOI: 10.3201/eid1604.090680
6. Sammons JS, Toltzis P. Recent trends in the epidemiology and treatment of C. difficile infection in children. Curr Opin Pediatr 2013; 25: 116-121. [PMID: 23241874. DOI: 10.1097/MOP.obo13e32835bf6c0
7. Zilberberg MD, Tabak YP, Sievert DM, Derby KG, Johannes RS, Sun X, McDonald LC. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol 2011; 32: 649-655. [PMID: 21666394. DOI: 10.1086/660360
8. Evans CT, Safdar N. Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection. Clin Infect Dis 2015; 60 Suppl 2: S66-S71. [PMID: 25922403. DOI: 10.1093/cid/civ140
9. Lessa FC, Winston LG, McDonald LC. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372: 2369-2370. [PMID: 26061850. DOI: 10.1056/NEJMc1505190
10. Kwon JH, Olsen MA, Dubberke ER. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am 2015; 29: 123-134. [PMID: 25677706. DOI: 10.1016/j.idc.2014.11.003
11. McFarland LV. Antibiotic-Associated diarrhea: epidemiology, trends and treatment. Future Microbiol 2008; 3: 563-578. [PMID: 18811240. DOI: 10.2217/17460913.3.5.563
12. Crews JD, Koo HL, Jiang ZD, Starke JR, DuPont HL. A hospitalbased study of the clinical characteristics of Clostridium difficile infection in children. Pediatr Infect Dis J 2014; 33: 924-928. [PMID: 25361022. DOI: 10.1097/INF.0000000000000338
13. Na JY, Park JM, Lee KS, Kang JO, Oh SH, Kim YJ. Clinical Characteristics of Symptomatic Clostridium difficile Infection in Children: Conditions as Infection Risks and Whether Probiotics Is Effective. Pediatr Gastroenterol Hepatol Nutr 2014; 17: 232-238. [PMID: 25587523. DOI: 10.5223/pghn.2014.17.4.232
14. Nylund CM, Goudie A, Garza JM, Fairbrother G, Cohen MB. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011; 165: 451-457. [PMID: 21199971. DOI: 10.1001/archpediatrics.2010.282
15. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010; 51: 2-7. [PMID: 20512057. DOI: 10.1097/MPG.0b013e3181d29767
16. World Health Organization. WHO definition of diarrhea. Accessed on November 13, 2015. Available from: URL: http://www.who.int/topics/diarrhoea/en/
17. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community-Acquired Clostridium difficile infection: a populationbased study. Am J Gastroenterol 2012; 107: 89-95. [PMID: 22108454. DOI: 10.1038/ajg.2011.398
18. Duleba K, Pawlowska M, Wietlicka-Piszcz M. Clostridium difficile infection in children hospitalized due to diarrhea. Eur J Clin Microbiol Infect Dis 2014; 33: 201-209. [PMID: 24213847. DOI: 10.1007/s10096-013-1946-1
19. McFarland LV, Goh S. Preventing Pediatric Antibiotic-Associated Diarrhea and Clostridium difficile Infections with Probiotics: a meta-Analysis. World J Meta-Analysis 2013; 1: 102-120 [DOI: 10.13105/wjma.v1.i3.102
20. Alam S, Mushtaq M. Antibiotic associated diarrhea in children. Indian Pediatr 2009; 46: 491-496. [PMID: 19556659
21. Arvola T, Laiho K, Torkkeli S, Mykkänen H, Salminen S, Maunula L, Isolauri E. Prophylactic Lactobacillus GG reduces antibiotic-Associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104: e64. [PMID: 10545590
22. Asha NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibioticassociated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol 2006; 44: 2785-2791. [PMID: 16891493
23. Dietrich CG, Kottmann T, Alavi M. Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-Associated diarrhea. World J Gastroenterol 2014; 20: 15837-15844. [PMID: 25400470. DOI: 10.3748/wjg.v20.i42.15837
24. Pituch H, Obuch-Woszczatyñski P, Wultañska D, van Belkum A, Meisel-Mikolajczyk F, Luczak M. Laboratory diagnosis of antibiotic-Associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins. Diagn Microbiol Infect Dis 2007; 58: 71-75. [PMID: 17300901
25. Peled N, Pitlik S, Samra Z, Kazakov A, Bloch Y, Bishara J. Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-Associated diarrhea. Infect Control Hosp Epidemiol 2007; 28: 377-381. [PMID: 17385141
26. Högenauer C, Langner C, Beubler E, Lippe IT, Schicho R, Gorkiewicz G, Krause R, Gerstgrasser N, Krejs GJ, Hinterleitner TA. Klebsiella oxytoca as a causative organism of antibioticassociated hemorrhagic colitis. N Engl J Med 2006; 355: 2418-2426. [PMID: 17151365
27. Ackermann G, Thomalla S, Ackermann F, Schaumann R, Rodloff AC, Ruf BR. Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-Associated diarrhoea. J Med Microbiol 2005; 54: 149-153. [PMID: 15673508
28. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-455. [PMID: 20307191. DOI: 10.1086/651706
29. Lübbert C, John E, von Müller L. Clostridium difficile infection: guideline-based diagnosis and treatment. Dtsch Arztebl Int 2014; 111: 723-731. [PMID: 25404529. DOI: 10.3238/arztebl.2014.0723
30. McFarland LV. [Risk factor for antibiotic-Associated diarrhea. A review of the literature]. Ann Med Interne (Paris) 1998; 149: 261-266. [PMID: 9791558
31. Wiström J, Norrby SR, Myhre EB, Eriksson S, Granström G, Lagergren L, Englund G, Nord CE, Svenungsson B. Frequency of antibiotic-Associated diarrhoea in 2462 antibiotic-Treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001; 47: 43-50. [PMID: 11152430
32. Benno Y, Sawada K, Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 1984; 28: 975-986. [PMID: 6513816
33. Penders J, Vink C, Driessen C, London N, Thijs C, Stobberingh EE. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formulafed infants by real-Time PCR. FEMS Microbiol Lett 2005; 243: 141-147. [PMID: 15668012
34. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibioticassociated diarrhea in children. J Pediatr 1999; 135: 564-568. [PMID: 10547243
35. Xie C, Li J, Wang K, Li Q, Chen D. Probiotics for the prevention of antibiotic-Associated diarrhoea in older patients: a systematic review. Travel Med Infect Dis 2015; 13: 128-134. [PMID: 25805164. DOI: 10.1016/j.tmaid.2015.03.001
36. Lusk RH, Fekety FR, Silva J, Bodendorfer T, Devine BJ, Kawanishi H, Korff L, Nakauchi D, Rogers S, Siskin SB. Gastrointestinal side effects of clindamycin and ampicillin therapy. J Infect Dis 1977; 135 Suppl: S111-S119. [PMID: 850084
37. Elseviers MM, Van Camp Y, Nayaert S, Duré K, Annemans L, Tanghe A, Vermeersch S. Prevalence and management of antibiotic associated diarrhea in general hospitals. BMC Infect Dis 2015; 15: 129. [PMID: 25888351. DOI: 10.1186/s12879-015-08690
38. Sathyendran V, McAuliffe GN, Swager T, Freeman JT, Taylor SL, Roberts SA. Clostridium difficile as a cause of healthcareassociated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology. Eur J Clin Microbiol Infect Dis 2014; 33: 1741-1747. [PMID: 24810967. DOI: 10.1007/s10096-014-2139-2
39. Matsuki S, Ozaki E, Shozu M, Inoue M, Shimizu S, Yamaguchi N, Karasawa T, Yamagishi T, Nakamura S. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int Microbiol 2005; 8: 43-48. [PMID: 15906260
40. Khanna S, Baddour LM, Huskins WC, Kammer PP, Faubion WA, Zinsmeister AR, Harmsen WS, Pardi DS. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis 2013; 56: 1401-1406. [PMID: 23408679. DOI: 10.1093/cid/cit075
41. Kim K, DuPont HL, Pickering LK. Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-To-person spread. J Pediatr 1983; 102: 376-382. [PMID: 6827409. DOI: 10.1016/S0022-3476(83)80652-0
42. McFarland LV, Surawicz CM, Greenberg RN, Bowen KE, Melcher SA, Mulligan ME. Possible role of cross-Transmission between neonates and mothers with recurrent Clostridium difficile infections. Am J Infect Control 1999; 27: 301-303. [PMID: 10358237
43. Søes LM, Holt HM, Böttiger B, Nielsen HV, Torpdahl M, Nielsen EM, Ethelberg S, Mølbak K, Andreasen V, Kemp M, Olsen KE. The incidence and clinical symptomatology of Clostridium difficile infections in a community setting in a cohort of Danish patients attending general practice. Eur J Clin Microbiol Infect Dis 2014; 33: 957-967. [PMID: 24352841. DOI: 10.1007/s10096-013-2033-3
44. Sammons JS, Localio R, Xiao R, Coffin SE, Zaoutis T. Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis 2013; 57: 1-8. [PMID: 23532470
45. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204-210. [PMID: 2911306
46. Chopra T, Goldstein EJ. Clostridium difficile Infection in Long-Term Care Facilities: A Call to Action for Antimicrobial Stewardship. Clin Infect Dis 2015; 60 Suppl 2: S72-S76. [PMID: 25922404
47. Ferroni A, Merckx J, Ancelle T, Pron B, Abachin E, Barbut F, Larzul J, Rigault P, Berche P, Gaillard JL. Nosocomial outbreak of Clostridium difficile diarrhea in a pediatric service. Eur J Clin Microbiol Infect Dis 1997; 16: 928-933. [PMID: 9495676
48. Cartwright CP, Stock F, Beekmann SE, Williams EC, Gill VJ. PCR amplification of rRNA intergenic spacer regions as a method for epidemiologic typing of Clostridium difficile. J Clin Microbiol 1995; 33: 184-187. [PMID: 7699038
49. Delmée M, Verellen G, Avesani V, Francois G. Clostridium difficile in neonates: serogrouping and epidemiology. Eur J Pediatr 1988; 147: 36-40. [PMID: 3338476
50. Toltzis P, Kim J, Dul M, Zoltanski J, Smathers S, Zaoutis T. Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children. J Pediatr 2009; 154: 607-608. [PMID: 19324222. DOI: 10.1016/j.jpeds.2008.10.016
51. von Müller L, Mock M, Halfmann A, Stahlmann J, Simon A, Herrmann M. Epidemiology of Clostridium difficile in Germany based on a single center long-Term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. Int J Med Microbiol 2015; 305: 807-813. [PMID: 26341328. DOI: 10.1016/j.ijmm.2015.08.035
52. Stoesser N, Crook DW, Fung R, Griffiths D, Harding RM, Kachrimanidou M, Keshav S, Peto TE, Vaughan A, Walker AS, Dingle KE. Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-Associated infection. J Clin Microbiol 2011; 49: 3994-3996. [PMID: 21940476. DOI: 10.1128/JCM.05349-11
53. Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, Collignon A. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis 2012; 55: 1209-1215. [PMID: 22843784. DOI: 10.1093/cid/cis637
54. Hart J, Putsathit P, Knight DR, Sammels L, Riley TV, Keil A. Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies. Eur J Clin Microbiol Infect Dis 2014; 33: 1555-1564. [PMID: 24781004. DOI: 10.1007/s10096-014-2108-9
55. Gaynes R, Rimland D, Killum E, Lowery HK, Johnson TM, Killgore G, Tenover FC. Outbreak of Clostridium difficile infection in a long-Term care facility: association with gatifloxacin use. Clin Infect Dis 2004; 38: 640-645. [PMID: 14986246
56. Johnson S, Samore MH, Farrow KA, Killgore GE, Tenover FC, Lyras D, Rood JI, DeGirolami P, Baltch AL, Rafferty ME, Pear SM, Gerding DN. Epidemics of diarrhea caused by a clindamycinresistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999; 341: 1645-1651. [PMID: 10572152
57. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-Associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442-2449. [PMID: 16322602
58. Pépin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-Associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173: 1037-1042. [PMID: 16179431
59. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, Roberts T, Croyle K, Krystofiak S, Patel-Brown S, Pasculle AW, Paterson DL, Saul M, Harrison LH. A large outbreak of Clostridium difficile-Associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005; 26: 273-280. [PMID: 15796280
60. Jump RL, Riggs MM, Sethi AK, Pultz MJ, Ellis-Reid T, Riebel W, Gerding DN, Salata RA, Donskey CJ. Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA. Emerg Infect Dis 2010; 16: 827-829. [PMID: 20409374. DOI: 10.3201/eid1605.071606
61. Lam TS, Yuk MT, Tsang NC, Wong MH, Chuang SK. Clostridium difficile infection outbreak in a male rehabilitation ward, Hong Kong Special Administrative Region (China), 2011. Western Pac Surveill Response J 2012; 3: 59-60. [PMID: 23908942. DOI: 10.5365/wpsar.2012.3.4.001
62. Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, Gardam M, McGeer A, Hutchinson J, Moore D, Kelly S. Health care-Associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010; 50: 194-201. [PMID: 20025526. DOI: 10.1086/649213
63. Turck D, Bernet JP, Marx J, Kempf H, Giard P, Walbaum O, Lacombe A, Rembert F, Toursel F, Bernasconi P, Gottrand F, McFarland LV, Bloch K. Incidence and risk factors of oral antibiotic-Associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr 2003; 37: 22-26. [PMID: 12827001
64. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-Associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990; 162: 678-684. [PMID: 2387993
65. Huang H, Wu S, Chen R, Xu S, Fang H, Weintraub A, Nord CE. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. Anaerobe 2014; 30: 65-69. [PMID: 25219941. DOI: 10.1016/j.anaerobe.2014.08.015
66. Sandora TJ, Fung M, Flaherty K, Helsing L, Scanlon P, Potter-Bynoe G, Gidengil CA, Lee GM. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011; 30: 580-584. [PMID: 21233782. DOI: 10.1097/INF.0b013e31820bfb29
67. Tai E, Richardson LC, Townsend J, Howard E, Mcdonald LC. Clostridium difficile infection among children with cancer. Pediatr Infect Dis J 2011; 30: 610-612. [PMID: 21206395. DOI: 10.1097/INF.0b013e31820970d1
68. Samady W, Bush R, Pong A, Andrews A, Fisher ES. Predictors of Clostridium difficile infections in hospitalized children. J Hosp Med 2014; 9: 94-98. [PMID: 24343932. DOI: 10.1002/jhm.2135
69. de Blank P, Zaoutis T, Fisher B, Troxel A, Kim J, Aplenc R. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr 2013; 163: 699-705.e1. [PMID: 23477996. DOI: 10.1016/j.jpeds.2013.01.062
70. Benson L, Song X, Campos J, Singh N. Changing epidemiology of Clostridium difficile-Associated disease in children. Infect Control Hosp Epidemiol 2007; 28: 1233-1235. [PMID: 17926272
71. Pai S, Aliyu SH, Enoch DA, Karas JA. Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management. PLoS One 2012; 7: e51728. [PMID: 23300561 10.1371/journal.pone.0051728
72. Tschudin-Sutter S, Tamma PD, Naegeli AN, Speck KA, Milstone AM, Perl TM. Distinguishing community-Associated from hospitalassociated Clostridium difficile infections in children: implications for public health surveillance. Clin Infect Dis 2013; 57: 1665-1672. [PMID: 24046303. DOI: 10.1093/cid/cit581
73. Vesteinsdottir I, Gudlaugsdottir S, Einarsdottir R, Kalaitzakis E, Sigurdardottir O, Bjornsson ES. Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study. Eur J Clin Microbiol Infect Dis 2012; 31: 2601-2610. [PMID: 22441775
74. Vardakas KZ, Konstantelias AA , Loizidis G, Rafailidis PI, Falagas ME. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-Analysis. Int J Infect Dis 2012; 16: e768-e773. [PMID: 22921930. DOI: 10.1016/j.ijid.2012.07.010
75. Fellmeth G, Yarlagadda S, Iyer S. Epidemiology of communityonset Clostridium difficile infection in a community in the South of England. J Infect Public Health 2010; 3: 118-123. [PMID: 20869672. DOI: 10.1016/j.jiph.2010.07.002
76. Damrongmanee A, Ukarapol N. Incidence of antibiotic-Associated diarrhea in a pediatric ambulatory care setting. J Med Assoc Thai 2007; 90: 513-517. [PMID: 17427529
77. Corrêa NB, Péret Filho LA, Penna FJ, Lima FM, Nicoli JR. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-Associated diarrhea in infants. J Clin Gastroenterol 2005; 39: 385-389. [PMID: 15815206
78. Ruszczyñski M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-Associated diarrhoea in children. Aliment Pharmacol Ther 2008; 28: 154-161. [PMID: 18410562. DOI: 10.111/j.1365-2036.2008.03714.x
79. Can M, Beşirbellioglu BA, Avci IY, Beker CM, Pahsa A. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-Associated diarrhea: a prospective study. Med Sci Monit 2006; 12: PI19-PI22. [PMID: 16572062
80. Yapar N, Sener A, Karaca B, Yucesoy M, Tarakci H, Cakir N, Yuce A. Antibiotic-Associated diarrhea in a Turkish outpatient population: investigation of 288 cases. J Chemother 2005; 17: 77-81. [PMID: 15828448
81. Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, Bulpitt CJ. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335: 80. [PMID: 17604300
82. De La Cochetière MF, Durand T, Lalande V, Petit JC, Potel G, Beaugerie L. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol 2008; 56: 395-402. [PMID: 18209965
83. Young VB, Schmidt TM. Antibiotic-Associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004; 42: 1203-1206. [PMID: 15004076
84. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6: e280. [PMID: 19018661
85. Mitchell DK, Van R, Mason EH, Norris DM, Pickering LK. Prospective study of toxigenic Clostridium difficile in children given amoxicillin/clavulanate for otitis media. Pediatr Infect Dis J 1996; 15: 514-519. [PMID: 8783348
86. Chang HT, Krezolek D, Johnson S, Parada JP, Evans CT, Gerding DN. Onset of symptoms and time to diagnosis of Clostridium difficile-Associated disease following discharge from an acute care hospital. Infect Control Hosp Epidemiol 2007; 28: 926-931. [PMID: 17620239
87. Kutty PK, Benoit SR, Woods CW, Sena AC, Naggie S, Frederick J, Engemann J, Evans S, Pien BC, Banerjee SN, Engel J, McDonald LC. Assessment of Clostridium difficile-Associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol 2008; 29: 197-202. [PMID: 18241032. DOI: 10.1086/528813
88. Walters BA, Roberts R, Stafford R, Seneviratne E. Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy. Gut 1983; 24: 206-212. [PMID: 6826104
89. McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999; 20: 43-50. [PMID: 9927265
90. Figueroa I, Johnson S, Sambol SP, Goldstein EJ, Citron DM, Gerding DN. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis 2012; 55 Suppl 2: S104-S109. [PMID: 22752857. DOI: 10.1093/cid/cis357
91. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC. Epidemiology of recurrences or reinfections of Clostridium difficile-Associated diarrhea. J Clin Microbiol 2000; 38: 2386-2388. [PMID: 10835010
92. Johnston BC, Shamseer L, da Costa BR, Tsuyuki RT, Vohra S. Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics 2010; 126: e222-e231. [PMID: 20566617. DOI: 10.1542/peds.2009-3667
93. Shan LS, Hou P, Wang ZJ, Liu FR, Chen N, Shu LH, Zhang H, Han XH, Han XX, Cai XX, Shang YX, Vandenplas Y. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 2013; 4: 329-334. [PMID: 24311316
94. Gogate A, De A, Nanivadekar R, Mathur M, Saraswathi K, Jog A, Kulkarni MV. Diagnostic role of stool culture, & amp; toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. Indian J Med Res 2005; 122: 518-524. [PMID: 16518003
95. Vidrine SR, Cortina C, Black M, Vidrine SB. Simultaneous acute appendicitis and pseudomembranous colitis in a pediatric patient. J La State Med Soc 2012; 164: 265-267. [PMID: 23362591
96. McFarland LV, Bauwens JE, Melcher SA, Surawicz CM, Greenberg RN, Elmer GW. Ciprofloxacin-Associated Clostridium difficile disease. Lancet 1995; 346: 977-978. [PMID: 7564771
97. Denno DM, Shaikh N, Stapp JR, Qin X, Hutter CM, Hoffman V, Mooney JC, Wood KM, Stevens HJ, Jones R, Tarr PI, Klein EJ. Diarrhea etiology in a pediatric emergency department: a case control study. Clin Infect Dis 2012; 55: 897-904. [PMID: 22700832. DOI: 10.1093/cid/cis553
98. Kim J, Shaklee JF, Smathers S, Prasad P, Asti L, Zoltanski J, Dul M, Nerandzic M, Coffin SE, Toltzis P, Zaoutis T. Risk factors and outcomes associated with severe clostridium difficile infection in children. Pediatr Infect Dis J 2012; 31: 134-138. [PMID: 22031485. DOI: 10.1097/INF.0b013e3182352e2c
99. Castillo A, Löpez J, Panadero E, Cerdá J, Padilla B, Bustinza A. Conservative surgical treatment for toxic megacolon due to Clostridium difficile infection in a transplanted pediatric patient. Transpl Infect Dis 2012; 14: E34-E37. [PMID: 22726419. DOI: 10.1111/j.1399-3062.2012.00756.x
100. Morinville V, McDonald J. Clostridium difficile-Associated diarrhea in 200 Canadian children. Can J Gastroenterol 2005; 19: 497-501. [PMID: 16107901
101. Kyne L, Merry C, O?Connell B, Kelly A, Keane C, O?Neill D. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing 1999; 28: 107-113. [PMID: 10350405
102. Wenisch JM, Schmid D, Kuo HW, Simons E, Allerberger F, Michl V, Tesik P, Tucek G, Wenisch C. Hospital-Acquired Clostridium difficile infection: determinants for severe disease. Eur J Clin Microbiol Infect Dis 2012; 31: 1923-1930. [PMID: 22210266. DOI: 10.1007/s10096-011-1522-5
103. Hsu MS, Wang JT, Huang WK, Liu YC, Chang SC. Prevalence and clinical features of Clostridium difficile-Associated diarrhea in a tertiary hospital in northern Taiwan. J Microbiol Immunol Infect 2006; 39: 242-248. [PMID: 16783456
104. Fujitani S, George WL, Murthy AR. Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol 2011; 32: 220-228. [PMID: 21460506. DOI: 10.1086/658336
105. Khanafer N, Touré A, Chambrier C, Cour M, Reverdy ME, Argaud L, Vanhems P. Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care. World J Gastroenterol 2013; 19: 8034-8041. [PMID: 24307797. DOI: 10.3748/wjg.v19.i44.8034
106. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D. Clostridium difficile-Associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171: 466-472. [PMID: 15337727
107. See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, Holzbauer S, Dunn J, Farley MM, Lyons C, Johnston H, Phipps E, Perlmutter R, Anderson L, Gerding DN, Lessa FC. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis 2014; 58: 1394-1400. [PMID: 24604900. DOI: 10.1093/cid/ciu125
108. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235: 363-372. [PMID: 11882758
109. Koss K, Clark MA, Sanders DS, Morton D, Keighley MR, Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis 2006; 8: 149-154. [PMID: 16412077
110. Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum 2004; 47: 1620-1626. [PMID: 15540290
111. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271: 1913-1918. [PMID: 8201735
112. Selinger CP, Bell A, Cairns A, Lockett M, Sebastian S, Haslam N. Probiotic VSL#3 prevents antibiotic-Associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. J Hosp Infect 2013; 84: 159-165. [PMID: 23618760. DOI: 10.1016/j.jhin.2013.02.019
113. Song X, Bartlett JG, Speck K, Naegeli A, Carroll K, Perl TM. Rising economic impact of clostridium difficile-Associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol 2008; 29: 823-828. [PMID: 18643746. DOI: 10.1086/588756
114. Kale-Pradhan PB, Jassal HK, Wilhelm SM. Role of Lactobacillus in the prevention of antibiotic-Associated diarrhea: a meta-Analysis. Pharmacotherapy 2010; 30: 119-126. [PMID: 20099986. DOI: 10.1592/phco.30.2.119
115. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-Associated disease among inpatients at children?s hospitals in the United States, 2001-2006. Pediatrics 2008; 122: 1266-1270. [PMID: 19047244. DOI: 10.1532/peds.2008-0469
116. Mc Laughlin D, Friedmacher F, Puri P. The impact of Clostridium difficile on paediatric surgical practice: a systematic review. Pediatr Surg Int 2014; 30: 853-859. [PMID: 25008231. DOI: 10.1007/s00383-014-3543-5
117. Tabak YP, Zilberberg MD, Johannes RS, Sun X, McDonald LC. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol 2013; 34: 588-596. [PMID: 23651889. DOI: 10.1086/670621
118. Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, O'Connor L, Vaughan A, Crook DW, Wilcox MH, Peto TE. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 2012; 55 Suppl 2: S77-S87. [PMID: 22752869. DOI: 10.1093/cid/cis356
119. Gravel D, Miller M, Simor A, Taylor G, Gardam M, McGeer A, Hutchinson J, Moore D, Kelly S, Boyd D, Mulvey M. Health careassociated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009; 48: 568-576. [PMID: 19191641. DOI: 10.1086/596703
120. Bacci S, Mølbak K, Kjeldsen MK, Olsen KE. Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis 2011; 17: 976-982. [PMID: 21749757. DOI: 10.3201/eid/1706.101483
121. McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. Fluoroquinolone use and risk factors for Clostridium difficileassociated disease within a Veterans Administration health care system. Clin Infect Dis 2007; 45: 1141-1151. [PMID: 17918075
122. Wullt M, Odenholt I. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-Associated diarrhoea. J Antimicrob Chemother 2004; 54: 211-216. [PMID: 15163651
123. Bhangu S, Bhangu A, Nightingale P, Michael A. Mortality and risk stratification in patients with Clostridium difficile-Associated diarrhoea. Colorectal Dis 2010; 12: 241-246. [PMID: 19508548. DOI: 10.1111/j.1463-1318.2009.01832.x
124. Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007; 28: 123-130. [PMID: 17265392
125. McFarland LV. From yaks to yogurt: the history, development, and current use of probiotics. Clin Infect Dis 2015; 60 Suppl 2: S85-S90. [PMID: 25922406. DOI: 10.1093/cid/civ054
126. Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-Associated diarrhea. Cochrane Database Syst Rev 2011; (11): CD004827. [PMID: 22071814. DOI: 10.1002/14651858.CD004827.pub3
127. Dinleyici EC, Kara A, Ozen M, Vandenplas Y. Saccharomyces boulardii CNCM I-745 in different clinical conditions. Expert Opin Biol Ther 2014; 14: 1593-1609. [PMID: 24995675. DOI: 10.1517/14712598.2014.937419
128. Videlock EJ, Cremonini F. Meta-Analysis: probiotics in antibiotic-Associated diarrhoea. Aliment Pharmacol Ther 2012; 35: 1355-1369. [PMID: 22531096
129. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics for the prevention and treatment of antibiotic-Associated diarrhea: a systematic review and meta-Analysis. JAMA 2012; 307: 1959-1969. [PMID: 22570464. DOI: 10.1001/jama.2012.3507
130. Pattani R, Palda VA, Hwang SW, Shah PS. Probiotics for the prevention of antibiotic-Associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-Analysis. Open Med 2013; 7: e56-e67. [PMID: 24348885
131. McFarland LV. Systematic review and meta-Analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 2010; 16: 2202-2222. [PMID: 20458757. DOI: 10.3748/wjg.v16.i18.2202
132. Szajewska H, Horvath A, Kolodziej M. Systematic review with meta-Analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2015; 41: 1237-1245. [PMID: 25898944. DOI: 10.1111/apt.13214
133. Szajewska H, Kolodziej M. Systematic review with meta-Analysis: Lactobacillus rhamnosus GG in the prevention of antibioticassociated diarrhoea in children and adults. Aliment Pharmacol Ther 2015; 42: 1149-1157. [PMID: 26365389. DOI: 10.1111/apt.13404
134. Johnston BC, Ma SS, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, Guyatt GH. Probiotics for the prevention of Clostridium difficile-Associated diarrhea: a systematic review and metaanalysis. Ann Intern Med 2012; 157: 878-888. [PMID: 23362517
135. Goldstein EJ, Johnson S, Maziade PJ, McFarland LV, Trick W, Dresser L, Millette M, Mazloum H, Low DE. Pathway to Prevention of Nosocomial Clostridium difficile Infection. Clin Infect Dis 2015; 60 Suppl 2: S148-S158. [PMID: 25922401. DOI: 10.1093/cid/civ142
136. Srigley JA, Brooks A, Sung M, Yamamura D, Haider S, Mertz D. Inappropriate use of antibiotics and Clostridium difficile infection. Am J Infect Control 2013; 41: 1116-1118. [PMID: 23932828. DOI: 10.1016/j.ajic.2013.04.017
137. Johnson S, Maziade PJ, McFarland LV, Trick W, Donskey C, Currie B, Low DE, Goldstein EJ. Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis 2012; 16: e786-e792. [PMID: 22863358. DOI: 10.1016/j.ijid.2012.06.005
138. McFarland LV. Probiotics for the primary and secondary prevention of C. difficile infections: a meta-Analysis and systemic review. Antibiotics 2015; 4: 160-178 [DOI: 10.3390/antibiotics4020160
139. Souza DN, Jorge MT. The effect of Lactobacillus casei and Bifidobacterium breve on antibiotic-Associated diarrhea treatment: randomized double-blind clinical trial. Rev Soc Bras Med Trop 2012; 45: 112-116. [PMID: 22370839. DOI: 10.1590/S0037-86822012000100021
140. Ligny G. Le traitement par l?ultra-levure des troubles intestinaux secondaires a l?antibiotherapie etude en double aveugle et etude clinique simple. [Ultra-Levure treatment of intestinal disorders secondary to antibiotics, a double-blind study and an open clinical study] In French. Revue Française de Gastroentérologie 1975; 114: 45-50
141. Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, Sears P, Gorbach S. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis 2012; 12: 281-289. [PMID: 22321770. DOI: 10.1016/S1473-3099(11)70374-7
142. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, Garcia RJ, Brandmarker S, Bowen K, Borjal D, Elmer GW. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000; 31: 1012-1017. [PMID: 11049785
143. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002; 97: 1769-1775. [PMID: 12135033
144. Vardakas KZ, Polyzos KA, Patouni K, Rafailidis PI, Samonis G, Falagas ME. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents 2012; 40: 1-8. [PMID: 22398198. DOI: 10.1016/j.ijantimicag.2012.01.004
145. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-Associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45: 302-307. [PMID: 17599306
146. Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD, Leney M, Sloan S, Hay CA, Ambrosino DM. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010; 362: 197-205. [PMID: 20089970. DOI: 10.1056/NEJMoa0907635
147. Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis 2012; 55 Suppl 2: S154-S161. [PMID: 22752865. DOI: 10.1093/cid/cis462
148. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-Associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981-988. [PMID: 2494098
149. Borody T, Fischer M, Mitchell S, Campbell J. Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead. Expert Rev Gastroenterol Hepatol 2015; 9: 1379-1391. [PMID: 26414076
150. Jarrad AM, Karoli T, Blaskovich MA, Lyras D, Cooper MA. Clostridium difficile drug pipeline: challenges in discovery and development of new agents. J Med Chem 2015; 58: 5164-5185. [PMID: 25760275. DOI: 10.1021/jm5016846
151. Jirapinyo P, Densupsoontorn N, Thamonsiri N, Wongarn R. Prevention of antibiotic-Associated diarrhea in infants by probiotics. J Med Assoc Thai 2002; 85 Suppl 2: S739-S742. [PMID: 12403254
152. Ahmad K, Fatemeh F, Mehri N, Maryam S. Probiotics for the treatment of pediatric helicobacter pylori infection: a randomized double blind clinical trial. Iran J Pediatr 2013; 23: 79-84. [PMID: 23446685
153. Saneeyan H, Samira L, Hamid R. [Effectiveness of probiotic on treatment of Helicobacter pylori infection in children]. Iranian. J Isfahan Med School 2011; 29: 882-889
154. Seki H, Shiohara M, Matsumura T, Miyagawa N, Tanaka M, Komiyama A, Kurata S. Prevention of antibiotic-Associated diarrhea in children by Clostridium butyricum MIYAIRI. Pediatr Int 2003; 45: 86-90. [PMID: 12654076
155. La Rosa M, Bottaro G, Gulino N, Gambuzza F, Di Forti F, Inì G, Tornambè E. [Prevention of antibiotic-Associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children. A multicentric double-blind vs placebo study]. Minerva Pediatr 2003; 55: 447-452. [PMID: 14608267
156. Fox MJ, Ahuja KD, Robertson IK, Ball MJ, Eri RD. Can probiotic yogurt prevent diarrhoea in children on antibiotics? A doubleblind, randomised, placebo-controlled study. BMJ Open 2015; 5: e006474. [PMID: 25588782. DOI: 10.1136/bmjopen-2014-006474
157. Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-Associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005; 21: 583-590. [PMID: 15740542
158. Duman DG, Bor S, Ozütemiz O, Sahin T, Oʇuz D, Iştan F, Vural T, Sandkci M, Işksal F, Simşek I, Soytürk M, Arslan S, Sivri B, Soykan I, Temizkan A, Beşşk F, Kaymakoʇlu S, Kalayc C. Efficacy and safety of Saccharomyces boulardii in prevention of antibioticassociated diarrhoea due to Helicobacterpylori eradication. Eur J Gastroenterol Hepatol 2005; 17: 1357-1361. [PMID: 16292090
159. Allen SJ, Wareham K, Wang D, Bradley C, Sewell B, Hutchings H, Harris W, Dhar A, Brown H, Foden A, Gravenor MB, Mack D, Phillips CJ. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-Associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess 2013; 17: 1-140. [PMID: 24309198. DOI: 10.3310/hta17570
160. Pozzoni P, Riva A, Bellatorre AG, Amigoni M, Redaelli E, Ronchetti A, Stefani M, Tironi R, Molteni EE, Conte D, Casazza G, Colli A. Saccharomyces boulardii for the prevention of antibiotic-Associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2012; 107: 922-931. [PMID: 22472744. DOI: 10.1038/ajg.2012.56
161. Li D, Wang H, Tan M, Shao Y. Use of probiotics for prevention of antibiotic-Associated diarrhea in elderly patients. Weichang Bingxue 2010; 15: 154-156
162. Surawicz CM, McFarland LV, Elmer G, Chinn J. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 1989; 84: 1285-1287. [PMID: 2679049
163. Ouwehand AC, DongLian C, Weijian X, Stewart M, Ni J, Stewart T, Miller LE. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine 2014; 32: 458-463. [PMID: 24291194. DOI: 10.1016/j.vaccine.2013.11.053
164. Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-Acquired Clostridium difficileassociated diarrhea. J Infect Dis 1994; 169: 127-133. [PMID: 8277174
165. Levy DG, Stergachis A, McFarland LV, Van Vorst K, Graham DJ, Johnson ES, Park BJ, Shatin D, Clouse JC, Elmer GW. Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting. Clin Ther 2000; 22: 91-102. [PMID: 10688393
166. Meropol SB, Localio AR, Metlay JP. Risks and benefits associated with antibiotic use for acute respiratory infections: a cohort study. Ann Fam Med 2013; 11: 165-172. [PMID: 23508604
167. Chen KT, Stephens DJ, Anderson E, Acton R, Saltzman D, Hess DJ. Clostridium difficile infection in the pediatric surgery population. J Pediatr Surg 2012; 47: 1385-1389. [PMID: 22813801
168. Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song IS. The effects of probiotics on PPI-Triple therapy for Helicobacter pylori eradication. Helicobacter 2008; 13: 261-268. [PMID: 18665934. DOI: 10.1111/j.1523-5378.2008.00601.x
169. Deshpande A, Pant C, Anderson MP, Donskey CJ, Sferra TJ. Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence. Pediatr Infect Dis J 2013; 32: 1138-1140. [PMID: 23546535
170. Boenning DA, Fleisher GR, Campos JM, Hulkower CW, Quinlan RW. Clostridium difficile in a pediatric outpatient population. Pediatr Infect Dis 1982; 1: 336-338. [PMID: 7155966
171. Hyams JS, Feder H, Krause PJ, Frick J, McLaughlin JC, Furth T, Hine P. Occurrence of Clostridium difficile toxin-Associated gastroenteritis following antibiotic therapy for otitis media in young children. Pediatr Infect Dis 1984; 3: 433-436. [PMID: 6333674
172. Destura RV. Bacillus clausii in preventing antibiotic-Associated diarrhea among Filipino infants and children: A multi-center, randomized, open-label clinical trial of efficacy and safety. 2008. Accessed June 3, 2013. Available from: URL: http://en.sanofi.com/img/content/study/ENTER-L-01125-summary.pdf
173. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011; 53: 42-48. [PMID: 21653301. DOI: 10.1093/cid/cir301
174. Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM. Incidence of and risk factors for community-Associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis 2011; 11: 194. [PMID: 21762504. DOI: 10.1186/1471-2334-11-194
175. Jarvis WR, Schlosser J, Jarvis AA , Chinn RY. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009; 37: 263-270. [PMID: 19278754
176. Schwartz KL, Darwish I, Richardson SE, Mulvey MR, Thampi N. Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study. BMC Pediatr 2014; 14: 28. [PMID: 24485120. DOI: 10.1186/1471-2431-14-28
177. Kociolek LK, Patel SJ, Shulman ST, Gerding DN. Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study. Infect Control Hosp Epidemiol 2015; 36: 445-451. [PMID: 25782900. DOI: 10.1017/ice.2014.89
178. Garg S, Mirza YR, Girotra M, Kumar V, Yoselevitz S, Segon A, Dutta SK. Epidemiology of Clostridium difficile-Associated disease (CDAD): a shift from hospital-Acquired infection to long-Term care facility-based infection. Dig Dis Sci 2013; 58: 3407-3412. [PMID: 24154638. DOI: 10.1007/s10620-013-2848-x
179. Leung J, Burke B, Ford D, Garvin G, Korn C, Sulis C, Bhadelia N. Possible association between obesity and Clostridium difficile infection. Emerg Infect Dis 2013; 19: 1791-1798. [PMID: 24188730. DOI: 10.3201/eid1911.130618
180. Kazakova SV, Ware K, Baughman B, Bilukha O, Paradis A, Sears S, Thompson A, Jensen B, Wiggs L, Bessette J, Martin J, Clukey J, Gensheimer K, Killgore G, McDonald LC. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006; 166: 2518-2524. [PMID: 17159019
181. Nylund CM, Eide M, Gorman GH. Association of Clostridium difficile infections with acid suppression medications in children. J Pediatr 2014; 165: 979-984.e1. [PMID: 25112692. DOI: 10.1016/j.jpeds.2014.06.062
182. El Feghaly RE, Stauber JL, Deych E, Gonzalez C, Tarr PI, Haslam DB. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis 2013; 56: 1713-1721. [PMID: 23487367. DOI: 10.1093/cid/cit147
183. Carignan A, Allard C, Pépin J, Cossette B, Nault V, Valiquette L. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008; 46: 1838-1843. [PMID: 18462108. DOI: 10.1086/588291
184. Crabtree TD, Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG. Clinical characteristics and antibiotic utilization in surgical patients with Clostridium difficile-Associated diarrhea. Am Surg 1999; 65: 507-511; discussion 511-512. [PMID: 10366203
185. See I, Bagchi S, Booth S, Scholz D, Geller AI, Anderson L, Moulton-Meissner H, Finks JL, Kelley K, Gould CV, Patel PR. Outbreak of Clostridium difficile Infections at an Outpatient Hemodialysis Facility-Michigan, 2012-2013. Infect Control Hosp Epidemiol 2015; 36: 972-974. [PMID: 25913501. DOI: 10.1017/ice.2015.90
186. Scardina T, Labus z ewski L, Pa che co SM, Adams W, Schreckenberger P, Johnson S. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting. Infect Control Hosp Epidemiol 2015; 36: 280-286. [PMID: 25695169. DOI: 10.1017/ice.2014.45
187. Hourigan SK, Oliva-Hemker M, Hutfless S. The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Dig Dis Sci 2014; 59: 2222-2227. [PMID: 24788321. DOI: 10.1007/s10620-014-3169-4
188. Kelsen JR, Kim J, Latta D, Smathers S, McGowan KL, Zaoutis T, Mamula P, Baldassano RN. Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 50-55. [PMID: 20722068. DOI: 10.1002/ibd.21421
189. Hu MY, Katchar K, Kyne L, Maroo S, Tummala S, Dreisbach V, Xu H, Leffler DA, Kelly CP. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology 2009; 136: 1206-1214. [PMID: 19162027. DOI: 10.1053/j.gastro.2008.12.038
190. Beaulieu M, Williamson D, Pichette G, Lachaine J. Risk of Clostridium difficile-Associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit. Infect Control Hosp Epidemiol 2007; 28: 1305-1307. [PMID: 17926283. DOI: 10.1086/521664
191. Marwick CA, Yu N, Lockhart MC, McGuigan CC, Wiuff C, Davey PG, Donnan PT. Community-Associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control. J Antimicrob Chemother 2013; 68: 2927-2933. [PMID: 23825381. DOI: 10.1093/jac/dkt257
192. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-Associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007; 45: 1543-1549. [PMID: 18190314. DOI: 10.1086/523582
193. Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt) 2007; 8: 557-566. [PMID: 18171114. DOI: 10.1089/sur.2006.062
194. Brown KE, Knoderer CA, Nichols KR, Crumby AS. Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients. Clin Pediatr (Phila) 2015; 54: 1102-1106. [PMID: 25644650. DOI: 10.1177/0009922815569201
195. Lee KS, Shin WG, Jang MK, Kim HS, Kim HS, Park CJ, Lee JY, Kim KH, Park JY, Lee JH, Kim HY, Cho SJ, Yoo JY. Who are susceptible to pseudomembranous colitis among patients with presumed antibiotic-Associated diarrhea? Dis Colon Rectum 2006; 49: 1552-1558. [PMID: 17028914
196. Enoch DA, Butler MJ, Pai S, Aliyu SH, Karas JA. Clostridium difficile in children: colonisation and disease. J Infect 2011; 63: 105-113. [PMID: 21664931. DOI: 10.1016/j.jinf.2011.05.016
197. James AH, Katz VL, Dotters DJ, Rogers RG. Clostridium difficile infection in obstetric and gynecologic patients. South Med J 1997; 90: 889-892. [PMID: 9305296
198. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-Associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010; 182: 1058-1064. [PMID: 20522788. DOI: 10.1164/rccm.200912-1853OC
199. Bruns AH, Oosterheert JJ, Kuijper EJ, Lammers JW, Thijsen S, Troelstra A, Hoepelman AI. Impact of different empirical antibiotic treatment regimens for community-Acquired pneumonia on the emergence of Clostridium difficile. J Antimicrob Chemother 2010; 65: 2464-2471. [PMID: 20823105. DOI: 10.1093/jac/dkq329
200. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control 2013; 41: 390-393. [PMID: 23622704. DOI: 10.1016/j.ajic.2012.09.023
201. McFarland LV, Elmer GW, Stamm WE, Mulligan ME. Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients. Infect Immun 1991; 59: 2456-2462. [PMID: 2050409
202. Ramanathan S, Johnson S, Burns SP, Kralovic SM, Goldstein B, Smith B, Gerding DN, Evans CT. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder. Am J Infect Control 2014; 42: 168-173. [PMID: 24485372. DOI: 10.1016/j.ajic.2013.08.009
203. Qualman SJ, Petric M, Karmali MA, Smith CR, Hamilton SR. Clostridium difficile invasion and toxin circulation in fatal pediatric pseudomembranous colitis. Am J Clin Pathol 1990; 94: 410-416. [PMID: 1699407
204. Rivlin J, Lerner A, Augarten A, Wilschanski M, Kerem E, Ephros MA. Severe Clostridium difficile-Associated colitis in young patients with cystic fibrosis. J Pediatr 1998; 132: 177-179. [PMID: 9470027
205. Nicholson MR, Thomsen IP, Slaughter JC, Creech CB, Edwards KM. Novel risk factors for recurrent Clostridium difficile infection in children. J Pediatr Gastroenterol Nutr 2015; 60: 18-22. [PMID: 25199038. DOI: 10.1097/MPG.0000000000000553
206. Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, Jiang Z, Garey KW. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. J Hosp Infect 2013; 85: 28-32. [PMID: 23834988. DOI: 10.1016/j.jhin.2013.04.017
207. Bartlett JG. Clinical practice. Antibiotic-Associated diarrhea. N Engl J Med 2002; 346: 334-339. [PMID: 11821511
208. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995; 38: 350-354. [PMID: 7720439
209. Khanna S, Pardi DS, Aronson SL, Kammer PP, Baddour LM. Outcomes in community-Acquired Clostridium difficile infection. Aliment Pharmacol Ther 2012; 35: 613-618. [PMID: 22229532. DOI: 10.1111/j.1365-2036.2011.04984.x
210. Sailhamer EA, Carson K, Chang Y, Zacharias N, Spaniolas K, Tabbara M, Alam HB, DeMoya MA, Velmahos GC. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg 2009; 144: 433-439; discussion 439-440. [PMID: 19451485. DOI: 10.1001/archsurg.2009.51
211. van der Wilden GM, Chang Y, Cropano C, Subramanian M, Schipper IB, Yeh DD, King DR, de Moya MA, Fagenholz PJ, Velmahos GC. Fulminant Clostridium difficile colitis: prospective development of a risk scoring system. J Trauma Acute Care Surg 2014; 76: 424-430. [PMID: 24458048. DOI: 10.1097/TA.0000000000000105
212. Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect Control Hosp Epidemiol 2007; 28: 932-940. [PMID: 17620240
213. Dubberke ER, Butler AM, Reske KA, Agniel D, Olsen MA, D' Angelo G, McDonald LC, Fraser VJ. Attributable outcomes of endemic Clostridium difficile-Associated disease in nonsurgical patients. Emerg Infect Dis 2008; 14: 1031-1038. [PMID: 18598621. DOI: 10.3201/eid1407.070867
214. Halabi WJ, Nguyen VQ, Carmichael JC, Pigazzi A, Stamos MJ, Mills S. Clostridium difficile colitis in the United States: a decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy. J Am Coll Surg 2013; 217: 802-812. [PMID: 24011436. DOI: 10.1016/j.jamcollsurg.2013.05.028
215. Kamdeu Fansi AA, Guertin JR, LeLorier J. Savings from the use of a probiotic formula in the prophylaxis of antibiotic-Associated diarrhea. J Med Econ 2012; 15: 53-60. [PMID: 22023067. DOI: 10.3111/13696998.2011.629015
216. Dubberke ER, Schaefer E, Reske KA, Zilberberg M, Hollenbeak CS, Olsen MA. Attributable inpatient costs of recurrent Clostridium difficile infections. Infect Control Hosp Epidemiol 2014; 35: 1400-1407. [PMID: 25333435. DOI: 10.1086/678428
217. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short-And long-Term attributable costs of Clostridium difficileassociated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46: 497-504. [PMID: 18197759
218. Abdelsattar ZM, Krapohl G, Alrahmani L, Banerjee M, Krell RW, Wong SL, Campbell DA, Aronoff DM, Hendren S. Postoperative burden of hospital-Acquired Clostridium difficile infection. Infect Control Hosp Epidemiol 2015; 36: 40-46. [PMID: 25627760. DOI: 10.1017/ice.2014.8
219. You E, Song H, Cho J, Lee J. Reduction in the incidence of hospital-Acquired Clostridium difficile infection through infection control interventions other than the restriction of antimicrobial use. Int J Infect Dis 2014; 22: 9-10. [PMID: 24583565. DOI: 10.1016/j.ijid.2014.01.011
220. Kallen AJ, Thompson A, Ristaino P, Chapman L, Nicholson A, Sim BT, Lessa F, Sharapov U, Fadden E, Boehler R, Gould C, Limbago B, Blythe D, McDonald LC. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol 2009; 30: 264-272. [PMID: 19215193. DOI: 10.1086/595694
221. Kim YS, Jeon H, Nam S, Cho BM, Park SH, Oh SM. Analysis of clinical characteristics and risk factors to neurosurgical patients with C. difficile-Associated diarrhea. J Kor Neurotraumatol Soc 2011; 7: 92-98
222. Wenisch C, Parschalk B, Hasenhündl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-Associated diarrhea. Clin Infect Dis 1996; 22: 813-818. [PMID: 8722937
223. Wullt M, Hagslätt ML, Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-Associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 2003; 35: 365-367. [PMID: 12953945
224. van Nood E, Dijkgraaf MG, Keller JJ. Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 2145. [PMID: 23718168
225. Cammarota G, Masucci L, Ianiro G, Bibbó S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2015; 41: 835-843. [PMID: 25728808. DOI: 10.1111/apt.13144